Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Around 0.3% of newborns will develop autoimmunity to pancreatic beta cells in childhood and subsequently develop type 1 diabetes before adulthood. Primary prevention of type 1 diabetes will require early intervention in genetically at-risk infants. The objective of this study was to determine to what extent genetic scores (two previous genetic scores and a merged genetic score) can improve the prediction of type 1 diabetes. METHODS AND FINDINGS: The Environmental Determinants of Diabetes in the Young (TEDDY) study followed genetically at-risk children at 3- to 6-monthly intervals from birth for the development of islet autoantibodies and type 1 diabetes. Infants were enrolled between 1 September 2004 and 28 February 2010 and monitored until 31 May 2016. The risk (positive predictive value) for developing multiple islet autoantibodies (pre-symptomatic type 1 diabetes) and type 1 diabetes was determined in 4,543 children who had no first-degree relatives with type 1 diabetes and either a heterozygous HLA DR3 and DR4-DQ8 risk genotype or a homozygous DR4-DQ8 genotype, and in 3,498 of these children in whom genetic scores were calculated from 41 single nucleotide polymorphisms. In the children with the HLA risk genotypes, risk for developing multiple islet autoantibodies was 5.8% (95% CI 5.0%-6.6%) by age 6 years, and risk for diabetes by age 10 years was 3.7% (95% CI 3.0%-4.4%). Risk for developing multiple islet autoantibodies was 11.0% (95% CI 8.7%-13.3%) in children with a merged genetic score of >14.4 (upper quartile; n = 907) compared to 4.1% (95% CI 3.3%-4.9%, P < 0.001) in children with a genetic score of ≤14.4 (n = 2,591). Risk for developing diabetes by age 10 years was 7.6% (95% CI 5.3%-9.9%) in children with a merged score of >14.4 compared with 2.7% (95% CI 1.9%-3.6%) in children with a score of ≤14.4 (P < 0.001). Of 173 children with multiple islet autoantibodies by age 6 years and 107 children with diabetes by age 10 years, 82 (sensitivity, 47.4%; 95% CI 40.1%-54.8%) and 52 (sensitivity, 48.6%, 95% CI 39.3%-60.0%), respectively, had a score >14.4. Scores were higher in European versus US children (P = 0.003). In children with a merged score of >14.4, risk for multiple islet autoantibodies was similar and consistently >10% in Europe and in the US; risk was greater in males than in females (P = 0.01). Limitations of the study include that the genetic scores were originally developed from case-control studies of clinical diabetes in individuals of mainly European decent. It is, therefore, possible that it may not be suitable to all populations. CONCLUSIONS: A type 1 diabetes genetic score identified infants without family history of type 1 diabetes who had a greater than 10% risk for pre-symptomatic type 1 diabetes, and a nearly 2-fold higher risk than children identified by high-risk HLA genotypes alone. This finding extends the possibilities for enrolling children into type 1 diabetes primary prevention trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In those individuals who are islet autoantibody positive, HLA-DR-DQ genotyping or an analysis of Genetic Risk Score (388,392) will help define the risk of type 1 diabetes.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [392]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A genetic risk score may be used at birth to identify children with a particularly high genetic risk of development of islet autoimmunity or type 1 diabetes (388,390,392).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [392]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 1×
“uk/) [20] and data for controls and cases from the WTCCC [21], and calculated the Winkler and Oram scores in 4,371 nondiabetic individuals who were heterozygous for HLA DR3-DQA1 0501-DQB1 0201 and DR4-DQA1 030X-DQB1 0302 (HLA DR3/DR4-DQ8) or who were homozygous for HLA DR4-DQA1 030X-DQB1 0302 (HLA DR4-DQ8/DR4-DQ8) (co…”
Kass, R. E., & Raftery, A. E. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476572 · Cited by 12,558
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Randomized trial of peanut consumption in infants at risk for peanut allergy
Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414850 · Cited by 2,237
Blanche, P., Dartigues, J., & Jacqmin‐Gadda, H. (2013) · Statistics in Medicine · doi:10.1002/sim.5958 · Cited by 1,852
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Self-citationSeroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Self-citationInsel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216 · cited 1×
“The presence of 2 or more islet autoantibodies (multiple islet autoantibodies) in genetically at-risk children defines a pre-symptomatic stage of type 1 diabetes where progression to type 1 diabetes is around 80% over 10 years [18,19].”
Self-citation
Cited by
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Self-citationPancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Towards clinical utility of polygenic risk scores
Lambert, S. A., Abraham, G., & Inouye, M. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz187 · Cited by 575
Sharp, S. A., Rich, S. S., Wood, A. R., Jones, S. E., Beaumont, R. N., Harrison, J. W., Schneider, D. A., Locke, J. M., Tyrrell, J., Weedon, M. N., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1785 · Cited by 366
“Previous T1D genetic scores captured the commonest and best described HLA class 2 DR3-DQ2 and DR4-DQ8 risk alleles (4,15,16), a single protective allele (DR15-DQ6) (16), and two class 1 alleles (HLA A*24 and HLA B*57) (4,16).”
BackgroundResultSelf-citationSacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Self-citationBattaglia, M., Ahmed, S., Anderson, M. S., Atkinson, M. A., Becker, D., Bingley, P. J., Bosi, E., Brusko, T. M., DiMeglio, L. A., Evans-Molina, C., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0880 · Cited by 351
Self-citationYield of a public health screening of children for islet autoantibodies in Bavaria, Germany
Ziegler, A.-G., Kick, K., Bonifacio, E., Haupt, F., Hippich, M., Dunstheimer, D., Lang, M., Laub, O., Warncke, K., Lange, K., et al. (2020) · JAMA · doi:10.1001/jama.2019.21565 · Cited by 312
Self-citationGenetic Risk Scores for Diabetes Diagnosis and Precision Medicine
Udler, M. S., McCarthy, M. I., Florez, J. C., & Mahajan, A. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00088 · Cited by 302
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A.-S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 168
Redondo, M. J., Geyer, S., Steck, A. K., Sharp, S., Wentworth, J. M., Weedon, M. N., Antinozzi, P., Sosenko, J., Atkinson, M., Pugliese, A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0087 · Cited by 174
Self-citationSacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 208
Self-citationBesser, R. E. J., Bell, K. J., Couper, J., Ziegler, A., Wherrett, D. K., Knip, M., Speake, C., Casteels, K., Driscoll, K. A., Jacobsen, L. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13410 · Cited by 189
Self-citationHaller, M. J., Bell, K. J., Besser, R. E. J., Casteels, K., Couper, J. J., Craig, M. E., Elding Larsson, H., Jacobsen, L., Lange, K., Oron, T., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543035 · Cited by 151
“These, and other risk regions, are included in (poly)genetic risk scores (GRS) that combine HLA and non-HLA genes to substantially improve risk estimates for islet autoimmunity and T1D, particularly in the general population [16, 20 – 22].”
InfluentialSelf-citationA combined risk score enhances prediction of type 1 diabetes among susceptible children
Ferrat, L. A., Vehik, K., Sharp, S. A., Lernmark, Å., Rewers, M. J., She, J.-X., Ziegler, A.-G., Toppari, J., Akolkar, B., Krischer, J. P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0930-4 · Cited by 148
Self-citationThe Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update
the TEDDY Study Group, Rewers, M., Hyöty, H., Lernmark, Å., Hagopian, W., She, J.-X., Schatz, D., Ziegler, A.-G., Toppari, J., Akolkar, B., et al. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1113-2 · Cited by 135
Self-citationHummel, S., Carl, J., Friedl, N., Winkler, C., Kick, K., Stock, J., Reinmüller, F., Ramminger, C., Schmidt, J., Lwowsky, D., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05953-0 · Cited by 129
“Genotyping for 46 SNPs, which have been used to calculate a genetic risk score (GRS) as described previously [28], was performed if consent for ancillary research was provided.”
MethodSelf-citationOnengut-Gumuscu, S., Chen, W.-M., Robertson, C. C., Bonnie, J. K., Farber, E., Zhu, Z., Oksenberg, J. R., Brant, S. R., Bridges, S. L., Edberg, J. C., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1727 · Cited by 128
Self-citationPrediction and Prevention of Type 1 Diabetes
Primavera, M., Giannini, C., & Chiarelli, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00248 · Cited by 147
Early-life factors contributing to type 1 diabetes
Craig, M. E., Kim, K. W., Isaacs, S. R., Penno, M. A. S., Hamilton‐Williams, E. E., Couper, J., & Rawlinson, W. D. (2019) · Diabetologia · doi:10.1007/s00125-019-4942-x · Cited by 123
Type 1 diabetes in diverse ancestries and the use of genetic risk scores
REDONDO, M. J., Gignoux, C. R., Dabelea, D., Hagopian, W., Önengüt-Gümüşcü, S., Oram, R. A., & Rich, S. S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00159-0 · Cited by 119
Self-citationZiegler, A.-G., Achenbach, P., Berner, R., Casteels, K., Danne, T., Gündert, M., Hasford, J., Hoffmann, V. S., Kordonouri, O., Lange, K., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028578 · Cited by 89
Self-citationSystematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes
Padilla-Martínez, F., Collin, F., Kwaśniewski, M., & Kretowski, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051703 · Cited by 106
Polygenic risk scores: An overview from bench to bedside for personalised medicine
Cross, B., Turner, R. M., & Pirmohamed, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1000667 · Cited by 97
Phillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E. E., Colhoun, H. M., Couper, J., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06205-5 · Cited by 159
Self-citationUtility of genetic risk scores in type 1 diabetes
Luckett, A. M., Weedon, M. N., Hawkes, G., Leslie, R. D., Oram, R. A., & Grant, S. F. A. (2023) · Diabetologia · doi:10.1007/s00125-023-05955-y · Cited by 80
“1 3 et al and Oram et al GRSs [7, 21] and tested this ‘merged’ GRS in the TEDDY study [59].”
BackgroundSelf-citationPhillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E., Colhoun, H. M., Couper, J. J., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0042 · Cited by 79
Self-citationImmunological biomarkers for the development and progression of type 1 diabetes
Mathieu, C., Lahesmaa, R., Bonifacio, E. E., Achenbach, P., & Tree, T. I. M. (2018) · Diabetologia · doi:10.1007/s00125-018-4726-8 · Cited by 88
Self-citationWeiss, A., Zapardiel-Gonzalo, J., Voss, F., Jolink, M., Stock, J., Haupt, F., Kick, K., Welzhofer, T., Heublein, A., Winkler, C., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05780-9 · Cited by 74
Self-citationHeickman, L. K. W., DeBoer, M. D., & Fasano, A. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3309 · Cited by 78
Emerging Roles of Exosomes in T1DM
Pang, H., Luo, S., Xiao, Y., Xia, Y., Li, X., Huang, G., Xie, Z., & Zhou, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593348 · Cited by 71
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
Winkler, C., Haupt, F., Heigermoser, M., Zapardiel‐Gonzalo, J., Ohli, J., Faure, T., Kalideri, E., Hommel, A., Delivani, P., Berner, R., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12870 · Cited by 61
Self-citationOram, R. A., Sharp, S. A., Pihoker, C., Ferrat, L., Imperatore, G., Williams, A., Redondo, M. J., Wagenknecht, L., Dolan, L. M., Lawrence, J. M., et al. (2022) · Diabetes Care · doi:10.2337/dc20-2872 · Cited by 62
Self-citationThe Changing Epidemiology of Type 1 Diabetes: A Global Perspective
Bell, K. J., & Lain, S. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16501 · Cited by 78
Birth and coming of age of islet autoantibodies
Bonifacio, E. E., & Achenbach, P. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13360 · Cited by 66
Self-citationBonifacio, E., Weiß, A., Winkler, C., Hippich, M., Rewers, M. J., Toppari, J., Lernmark, Å., She, J.-X., Hagopian, W. A., Krischer, J. P., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2122 · Cited by 52
Self-citationElevations in blood glucose before and after the appearance of islet autoantibodies in children
Warncke, K., Weiß, A., Achenbach, P., Berge, T. V. D., Berner, R., Casteels, K., Groele, L., Hatzikotoulas, K., Hommel, A., Kordonouri, O., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci162123 · Cited by 59
Self-citationGirard, D., & Vandiedonck, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.991716 · Cited by 58
Hippich, M., Beyerlein, A., Hagopian, W. A., Krischer, J. P., Vehik, K., Knoop, J., Winker, C., Toppari, J., Lernmark, Å., Rewers, M. J., et al. (2019) · Diabetes · doi:10.2337/db18-0882 · Cited by 47
Self-citationOmics and Cardiometabolic Disease Risk Prediction
Tahir, U. A., & Gerszten, R. E. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-042418-010924 · Cited by 47
The future of type 1 diabetes therapy
Ziegler, A.-G., Cengiz, E., & Kay, T. W. H. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01438-2 · Cited by 42
Self-citationImmune Mechanisms and Pathways Targeted in Type 1 Diabetes
Jacobsen, L. M., Newby, B. N., Perry, D. J., Posgai, A. L., Haller, M. J., & Brusko, T. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1066-5 · Cited by 45
Ziegler, A., Arnolds, S., Koelln, A., Achenbach, P., Berner, R., Bonifacio, E. E., Casteels, K., Larsson, H. E., Gündert, M., Hasford, J., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052449 · Cited by 47
Self-citationClinical and research uses of genetic risk scores in type 1 diabetes
Sharp, S. A., Weedon, M. N., Hagopian, W., & Oram, R. A. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.03.009 · Cited by 46
Self-citationBeyerlein, A., Bonifacio, E., Vehik, K., Hippich, M., Winkler, C., Frohnert, B. I., Steck, A. K., Hagopian, W. A., Krischer, J. P., Lernmark, Å., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105532 · Cited by 39
Self-citationRoss, J. J., Wasserfall, C. H., Bacher, R. L., Perry, D. J., MCGRAIL, K. M., Posgai, A. L., Dong, X., MUIR, A. B., Li, X., Campbell‐Thompson, M., et al. (2021) · Diabetes · doi:10.2337/db20-0995 · Cited by 41
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
Lugar, M., Eugster, A., Achenbach, P., Berge, T. V. D., Berner, R., Besser, R. E. J., Casteels, K., Larsson, H. E., Gemulla, G., Kordonouri, O., et al. (2023) · JAMA · doi:10.1001/jama.2023.16348 · Cited by 38
Self-citationA classification and regression tree analysis identifies subgroups of childhood type 1 diabetes
Achenbach, P., Hippich, M., Zapardiel‐Gonzalo, J., Karges, B., Holl, R. W., Petrera, A., Bonifacio, E. E., & Ziegler, A. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104118 · Cited by 40
Self-citationBonifacio, E. E., & Ziegler, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16354 · Cited by 42
Self-citationExtracellular Vesicles in Type 1 Diabetes: A Versatile Tool
Suire, C. N., & Hade, M. D. (2022) · Bioengineering · doi:10.3390/bioengineering9030105 · Cited by 38
Webb‐Robertson, B., Bramer, L., Stanfill, B., Akers, S. M., Nakayasu, E. S., Metz, T., Frohnert, B. I., Norris, J. M., Johnson, R. K., Rich, S. S., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13093 · Cited by 35
Self-citationLooking back at the TEDDY study: lessons and future directions
Lernmark, Å., Agardh, D., Akolkar, B., Gesualdo, P., Hagopian, W., Haller, M. J., Hyöty, H., Johnson, S. B., Larsson, H. E., Liu, E., et al. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01045-0 · Cited by 38
Self-citationThe countdown to type 1 diabetes: when, how and why does the clock start?
Ziegler, A.-G. (2023) · Diabetologia · doi:10.1007/s00125-023-05927-2 · Cited by 30
Self-citationRoles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus
Gauthier, B. R., Cobo‐Vuilleumier, N., & López–Noriega, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1057407 · Cited by 31
Genetics Coming of Age in Type 1 Diabetes
Cerolsaletti, K., Hao, W., & Greenbaum, C. J. (2019) · Diabetes Care · doi:10.2337/dci18-0039 · Cited by 39
Karpov, D. S., Sosnovtseva, A. O., Pylina, S. V., Bastrich, A., Petrova, D. A., Kovalev, M. A., Shuvalova, A. I., Константиновна, Е. А., & Mokrysheva, N. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417320 · Cited by 35
PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses
Anderson, W., Barahmand-pour-Whitman, F., Linsley, P. S., Cerosaletti, K. M., Buckner, J. H., & Rawlings, D. J. (2023) · eLife · doi:10.7554/elife.81577 · Cited by 34
Endotypes in T1D: B lymphocytes and early onset
Smith, M. J., Cambier, J. C., & Gottlieb, P. A. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000547 · Cited by 29
Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem
Minniakhmetov, I. R., Yalaev, B. I., Khusainova, R. I., Bondarenko, E. V., Mel'nichenko, G. A., Dedov, I. I., & Mokrysheva, N. G. (2024) · Biomedicines · doi:10.3390/biomedicines12020399 · Cited by 32
Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
Deligne, C., You, S., & Mallone, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040542 · Cited by 27
Aydemir, Ö., Noble, J. A., Bailey, J. A., Lernmark, Å., Marsh, P. W., Svärd, A. A., Bearoff, F. M., Blankenhorn, E. P., Mordes, J. P., Better Diabetes Diagnosis (BDD) Study Group, et al. (2019) · Diabetes · doi:10.2337/db18-1128 · Cited by 26
Self-citationLaine, A., Valta, M., Toppari, J., Knip, M., Veijola, R., Ilonen, J., & Lempainen, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909020 · Cited by 30
Self-citationPossible heterogeneity of initial pancreatic islet beta‐cell autoimmunity heralding type 1 diabetes
Lernmark, Å., Akolkar, B., Hagopian, W., Krischer, J. P., McIndoe, R., Rewers, M., Toppari, J., Vehik, K., Ziegler, A., & The TEDDY Study Group (2023) · Journal of Internal Medicine · doi:10.1111/joim.13648 · Cited by 32
Self-citationDiabetes mellitus polygenic risk scores: heterogeneity and clinical translation
Ortega, H. I., Udler, M. S., Gloyn, A. L., & Sharp, S. A. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01132-w · Cited by 32
Yu, H., Raut, J. R., Schöttker, B., Holleczek, B., Zhang, Y., & Brenner, H. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00872-y · Cited by 22
Ziegler, A., Achenbach, P., Weiß, A., Berner, R., Casteels, K., Larsson, H. E., Haupt, F., Hommel, A., Jacobs, A., Kordonouri, O., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01726-x · Cited by 24
Self-citationPrediction of progression to type 1 diabetes with dynamic biomarkers and risk scores
Joglekar, M. V., Kaur, S., Pociot, F., & Hardikar, A. A. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00103-7 · Cited by 22
Elhag, D. A., Kumar, M., & Khodor, S. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010125 · Cited by 27
Next steps in the identification of gene targets for type 1 diabetes
Grant, S. F. A., Wells, A. D., & Rich, S. S. (2020) · Diabetologia · doi:10.1007/s00125-020-05248-8 · Cited by 22
Self-citationZou, H., Liu, L., Guo, J., Wang, H., Liu, S., Xing, Y., Deng, C., Xiao, Y., & Zhou, Z. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13387 · Cited by 21
Webb‐Robertson, B., Nakayasu, E. S., Frohnert, B. I., Bramer, L., Akers, S. M., Norris, J. M., Vehik, K., Ziegler, A., Metz, T., Rich, S. S., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac225 · Cited by 20
Self-citationAlazwari, A., Johnstone, A. C., Tafakori, L., Abdollahian, M., AlEidan, A., Alfuhigi, K., Alghofialy, M. M., Albunyan, A., Abbad, H. J. A., Alessa, M. H., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282426 · Cited by 21
Strengthening Causal Inference in Exposomics Research: Application of Genetic Data and Methods
Avery, C. L., Howard, A. G., Ballou, A. F., Buchanan, V. L., Collins, J. M., Downie, C. G., Engel, S. M., Graff, M., Highland, H. M., Lee, M. P., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp9098 · Cited by 21
New insights on the genetics of type 1 diabetes
Oram, R. A., & REDONDO, M. J. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000489 · Cited by 21
Self-citationUntangling the genetic link between type 1 and type 2 diabetes using functional genomics
Nyaga, D. M., Vickers, M. H., Jefferies, C., Fadason, T., & O'Sullivan, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-93346-x · Cited by 18
Alazwari, A., Abdollahian, M., Tafakori, L., Johnstone, A., Alshumrani, R. A., AlHelal, M., Alsaheel, A. Y., Almoosa, E. S., & Alkhaldi, A. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264118 · Cited by 15
Chan, J. C. N., Chow, E., Kong, A. P. S., Cheung, E. Y. N., Tony, O., Lim, C. K. P., Fan, B., Tsoi, S. T. F., Fan, Y., Shi, M., et al. (2024) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2023.36 · Cited by 18
Guertin, K. A., Repaske, D. R., Taylor, J. F., Williams, E. S., Önengüt-Gümüşcü, S., Chen, W., Boggs, S. R., Yu, L., Allen, L., Botteon, L., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01305-8 · Cited by 15
Self-citationObtaining a Genetic Family History Using Computer‐Based Tools
Li, W., Murray, M. F., & Giovanni, M. A. (2018) · Current Protocols in Human Genetics · doi:10.1002/cphg.72 · Cited by 12
Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions
Tosur, M., Önengüt-Gümüşcü, S., & REDONDO, M. J. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01575-5 · Cited by 16
Vasilev, G., Kokudeva, M., Siliogka, E., Padilla, N., Shumnalieva, R., Della‐Morte, D., Ricordi, C., Mihova, A., Infante, M., & Velikova, T. V. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i4.99936 · Cited by 12
Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter
Ferrat, L. A., Templeman, E. L., Steck, A. K., Parikh, H. M., You, L., Önengüt-Gümüşcü, S., Gottlieb, P. A., Triolo, T. M., Rich, S. S., Krischer, J. P., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06434-2 · Cited by 11
Self-citationAlbert, E. A., Kondratieva, O. A., Baranova, E., Sagaydak, O. V., Belenikin, M. S., Zobkova, G., Kuznetsova, E. S., Deviatkin, A. A., Zhurov, A. A., Karpulevich, E., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1086709 · Cited by 11
Chakraborty, H., Sun, Q. L., Bhupathiraju, S. N., Schenk, J. M., Mishchuk, D. O., Bain, J. R., He, X., Sun, J., Harnly, J. M., Simmons, W., et al. (2025) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2025.107435 · Cited by 9
The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study
Satpathy, S., Panigrahi, L. L., & Arakha, M. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266299494240326083936 · Cited by 10
Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives
Triolo, T. M., Parikh, H. M., Tosur, M., Ferrat, L. A., You, L., Gottlieb, P. A., Oram, R. A., Önengüt-Gümüşcü, S., Krischer, J. P., Rich, S. S., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae349 · Cited by 8
Self-citationZeller, I., Weiss, A., Arnolds, S., Schütte-Borkovec, K., Arabi, S., Berge, T. V. D., Casteels, K., Hommel, A., Kordonouri, O., Larsson, H. E., et al. (2024) · Infection · doi:10.1007/s15010-024-02312-y · Cited by 7
Self-citationGenomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders
Trajanoska, K., & Rivadeneira, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.556610 · Cited by 9
Önengüt-Gümüşcü, S., Webb‐Robertson, B., Sarkar, S., Manichaikul, A. W., Hu, X., Frazer‐Abel, A. A., Holers, V. M., Rewers, M., & Rich, S. S. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3716 · Cited by 9
Self-citationWhat Have Slow Progressors Taught Us About T1D—Mind the Gap!
Gillespie, K. M., & Long, A. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1219-1 · Cited by 9
Lindbladh, I., Svärd, A. A., & Lernmark, Å. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00041-5 · Cited by 9
Self-citationType 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening
Kahaly, G. J., Forst, T. M., Kellerer, M., Lanzinger, S., Rötzer, R. D., Schott, M., & Schumm‐Draeger, P. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70119 · Cited by 8
Sarkar, S., Zheng, X., Clair, G., Kwon, Y. M., You, Y., Swensen, A., Webb‐Robertson, B., Nakayasu, E. S., Qian, W.-J., & Metz, T. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.07.009 · Cited by 6
Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes
Steck, A. K., Parikh, H. M., Triolo, T. M., Ferrat, L. A., You, L., Gottlieb, P. A., Oram, R. A., Önengüt-Gümüşcü, S., Krischer, J. P., Rich, S. S., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf392 · Cited by 6
Self-citationHo, D., Nyaga, D. M., Schierding, W. S., Saffery, R., Perry, J. K., Taylor, J. A., Vickers, M. H., Kempa-Liehr, A. W., & O'Sullivan, J. M. (2021) · Communications Biology · doi:10.1038/s42003-021-02594-0 · Cited by 7
A Historical and Epistemological Review of Type 1 Diabetes Mellitus
Cavalli, E., Nicoletti, G. R. P., & Nicoletti, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144923 · Cited by 10
Emerging Diabetic Novel Biomarkers of the 21st Century
Suneja, S., Gangopadhyay, S., Saini, V., Dawar, R., & Kaur, C. (2021) · Annals of the National Academy of Medical Sciences (India) · doi:10.1055/s-0041-1726613 · Cited by 5
Bonnell, J., Alcazar, O., Watts, B. M., Buchwald, P., Abdulreda, M. H., & Ogihara, M. (2024) · Biomedicines · doi:10.3390/biomedicines12030492 · Cited by 7
Incomplete time-series gene expression in integrative study for islet autoimmunity prediction
Ahmed, K. T., Cheng, S. L. A., Li, Q., Yong, J., & Zhang, W. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac537 · Cited by 6
Ziegler, A., Rewers, M. J., Achenbach, P., Bell, K. J., Bonifacio, E., DiMeglio, L. A., Dutta, S., Larsson, H. E., Frohnert, B. I., Griffin, K., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06841-z · Cited by 7
Self-citation
Metadata
- Authors
- Bonifacio, E., Beyerlein, A., Hippich, M., Winkler, C., Vehik, K., Weedon, M. N., Laimighofer, M., Hattersley, A. T., Krumsiek, J., Frohnert, B. I., Steck, A. K., Hagopian, W. A., Krischer, J. P., Lernmark, Å., Rewers, M. J., She, J.-X., Toppari, J., Akolkar, B., Oram, R. A., Rich, S. S., Ziegler, A.-G., & for the TEDDY Study Group
- Affiliations
- Center for Regenerative Therapies Dresden (DE)
- TUM Klinikum (DE)
- University of South Florida (US)
- University of Exeter (GB)
- Helmholtz Munich (DE)
- University of Colorado Denver (US)
- Pacific Northwest Research Institute (US)
- Lund University (SE)
- Augusta University (US)
- University of Turku (FI)
- National Institutes of Health (US)
- University of Alberta (CA)
- University of Virginia (US)
- Corresponding author
- Ziegler, Anette-G.
- ORCID
- Bonifacio, Ezio
- Beyerlein, Andreas
- Hippich, Markus
- Winkler, Christiane
- Vehik, Kendra
- Weedon, Michael N.
- Laimighofer, Michael
- Hattersley, Andrew T.
- Krumsiek, Jan
- Frohnert, Brigitte I.
- Steck, Andrea K.
- Hagopian, William A.
- Krischer, Jeffrey P.
- Lernmark, Åke
- Rewers, Marian J.
- She, Jin-Xiong
- Toppari, Jorma
- Akolkar, Beena
- Oram, Richard A.
- Rich, Stephen S.
- Ziegler, Anette-G.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-04-03
- Volume
- 15
- Issue
- 4
- Pages
- e1002548
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5882115
- OpenAlex
- W2795575996
- Cited by
- 148
- References
- 36
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 19 · 2023: 19 · 2022: 23 · 2021: 12 · 2020: 16 · 2019: 15 · 2018: 11
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- UTUPub (University of Turku) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion, cc-by)
- Open Research Exeter (University of Exeter) (submittedVersion, public-domain)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
- Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, and Contract No. HHSN267200700014C)
- National Institute of Allergy and Infectious Diseases
- National Institute of Child Health and Human Development
- National Institute of Environmental Health Sciences
- Juvenile Diabetes Research Foundation International
- Centers for Disease Control and Prevention
- NIH/NCATS Clinical and Translational Science Awards (UL1 TR000064)
- University of Colorado (UL1 TR001082)
- iMed–the Helmholtz Initiative on Personalized Medicine
- DFG Research Center and Cluster of Excellence - Center for Regenerative Therapies Dresden (FZ 111)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes, islet autoantibodies, polygenic risk score, risk prediction, single nucleotide polymorphisms, TEDDY study, primary prevention, islet autoimmunity, risk stratification
- MeSH terms
- Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Family, Female, Genetic Testing, Humans, Infant, Infant, Newborn, Islets of Langerhans, Male, Risk Factors, Case-Control Studies, Risk Assessment, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.